Our Products
Loans
Cards
Insurance
Investment
Stock Market
Electronics Mall
CIBIL Score
Knowledge Centre
Academy 
Calculators
Our Services
My Account
Do not call
En
Nifty500 Multicap India Manufacturing 50:30:20
Nifty500 Multicap India Manufacturing 50:30:20 Performance
Day's Range
Low
₹16,967.55
High
₹17,032.60
52 Week Range
Low
₹14,148.20
High
₹17,180.30
| Previous Close | ₹16,943.90 |
|---|---|
| Day's Range | ₹16,967.55 - ₹17,032.60 |
| Open | ₹17,023.95 |
| 52 Week Range | ₹14,148.20 - ₹17,180.30 |
| Volume | 24,65,79,628 |
Nifty500 Multicap India Manufacturing 50:30:20 Companies
| Company Name | LTP (₹) | Change (₹) | Sector |
|---|---|---|---|
| Amara Raja Energy & Mobility Ltd. | 930.85 |  2.30 (0.25%) |
Automobile & Ancillaries |
| Atul Ltd. | 6510.50 |  -85.50 (-1.30%) |
Chemicals |
| Force Motors Ltd. | 17885.00 | 48.00 (0.27%) |
Automobile & Ancillaries |
| Bharat Electronics Ltd. | 409.40 | 0.20 (0.05%) |
Capital Goods |
| Chambal Fertilisers and Chemicals Ltd. | 433.95 | -0.90 (-0.21%) |
Chemicals |
| Exide Industries Ltd. | 464.10 | 4.60 (1.00%) |
Automobile & Ancillaries |
| Cipla Ltd. | 1438.00 | 16.00 (1.13%) |
Healthcare |
| Bharat Heavy Electricals Ltd. | 413.50 | -6.30 (-1.50%) |
Capital Goods |
| Hindustan Petroleum Corporation Ltd. | 363.20 | -3.25 (-0.89%) |
Crude Oil |
| Dr. Reddy's Laboratories Ltd. | 1180.00 | 10.00 (0.85%) |
Healthcare |
| Index Name | Market Value | 52W High | 52W Low |
|---|---|---|---|
| Nifty 50 | 24231.85 | 26373.20 | 22182.55 |
| Nifty IT | 30673.05 | 40301.40 | 25699.10 |
| Nifty Next 50 | 74194.15 | 74878.45 | 59896.10 |
| NIFTY50 USD Index | 8772.75 | 10443.40 | 8132.40 |
| Nifty Bank | 57495.9 | 61764.85 | 49954.85 |
| NIFTY Midcap 100 | 63671.55 | 64139.05 | 52032.85 |
| Nifty 500 | 23512.95 | 24144.20 | 20385.65 |
| Nifty Midcap 50 | 18300.65 | 18403.50 | 14804.55 |
| Nifty 100 | 25391.85 | 26975.15 | 22720.45 |
| Nifty FMCG | 47863.25 | 58485.05 | 45334.15 |
Latest News
Dr Reddys Laboratories informs about newspaper publication
Crompton Greaves Consumer Electricals informs about updates
Glenmark Pharmaceuticals informs about media release
Glenmark Pharmaceuticals has informed that, Glenmark Pharmaceuticals (Glenmark) today announced the receipt of U.S. FDA approval1 for Fluticasone Propionate Nasal Spray USP, 0.05 mg/spray. Glenmark’s Fluticasone Propionate Nasal Spray USP is bioequivalent and therapeutically equivalent to the reference listed drug, Flonase®2 Nasal Spray, 0.05 mg/spray of Haleon US Holdings LLC [NDA 020121] and will be distributed in the U.S. by Glenmark Pharmaceuticals Inc., USA. The company has attached media release.
The above information is a part of company’s filings submitted to BSE.
Chambal Fertilisers & Chemicals informs about disclosure
Chambal Fertilisers & Chemicals informs about SAST
No Records Found
Sign in to Unlock Offers!
We don't SPAM
Frequently Asked Questions
The previous close of Ny500MUL50:30:20 index is ₹16991.15 as of 2026-08-20.
The total volume of Ny500MUL50:30:20 index is 246579628.00 as of 2026-08-20.
The percentage change in value of Ny500MUL50:30:20 index is 0.28% as of 2026-08-20.
The absolute increase in Ny500MUL50:30:20 index value since the previous trading day is ₹47.25 as of 2026-08-20.
A stock reaching its 52-week high indicates it has attained its highest price point in the past year. This milestone may signal strong performance and positive investor sentiment. Please note that investments are subject to market risks.
Disclaimer
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.
